CLDF Title
Home | Contact Us | Bookmark
HBV HE HCC HCV
About CLDF Centers of Educational Expertise  
CME Dinner Meetings Webcasts Slide Library Abstract Library Conference Highlights
 
Back  
 
Reuters Health Information (2005-03-30): Bayer gets FDA nod for hepatitis A blood test

Regulatory

Bayer gets FDA nod for hepatitis A blood test

Last Updated: 2005-03-30 16:05:04 -0400 (Reuters Health)

FRANKFURT (Reuters) - German drugs and chemicals group Bayer has received the U.S. Food and Drug Administration's approval for its Hepatitis A Total assay, a diagnostic blood test, it said in a statement on Wednesday.

The assay measures anti-hepatitis A antibodies in blood, and can be used to aid diagnosis or to identify susceptible individuals for vaccination.

In the United States, Bayer now has two assays for the hepatitis A virus, three for hepatitis B and an assay for the detection of hepatitis C.

 
 
 
 
                 
 
HBV
Webcasts
Slide Library
Abstract Library
 
HE
CME Dinner Meeting
Webcasts
Slide Library
Abstract Library
 
HCC
Slide Library
Abstract Library
 
 
HCV
Webcasts
Slide Library
Abstract Library
 
CLDF Follow Us
   
 
About CLDF
Mission Statement
Board of Trustees
Board of Advisors
CLDF Supporters
 
Other Resources
Liver News Library
Journal Abstracts
Hep C Link to Care
 
Centers of
Educational Expertise
Regional Map
     
   
  The Chronic Liver Disease Foundation is a non-profit organization with content developed specifically for healthcare professionals.
© Copyright 2012-2014 Chronic Liver Disease Foundation. All rights reserved. This site is maintained as an educational resource for US healthcare providers only.
Use of this Web site is governed by the Chronic Liver Disease Foundation terms of use and privacy statement.